Phenylboronic acid modified polyethyleneimine alginate chitosan dynamic hydrogels combination with adipose derived stem cells for controlled delivery of BMP2 to promote bone regeneration and modulating macrophage and ang
Wang H., Zhao Z., Mou L., Li S., Jia X., Dong Y.
Animal Study on Immune Modulation, published in Int J Biol Macromol (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Int J Biol Macromol (2025)
- Country
- Netherlands
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 40972920
- DOI
- 10.1016/j.ijbiomac.2025.147767
- Citations
- 2
Abstract (original English)
Bone morphogenetic protein-2 (BMP2) has been approved by the United States Food and Drug Administration (FDA) to be used in human lumbar fusion to promote bone regeneration. However, BMP2 has a short half-life, rapid degradation, and burst release at high concentrations, which aggravates its adverse effects. A sodium alginate chitosan PEI-PBA-BMP2-ADSCs (SCPPBA) hydrogel was constructed. Hydrogel structure, biocompatibility, osteoinductivity, immunoregulation, and angiogenesis were evaluated. The SCPPBA hydrogel exhibited a porous structure, chemical crosslinking, moderate elastic modulus and viscosity, biocompatibility, biodegradation, and controlled and long-period BMP2 protein release. In an in vitro study, SCPPBA hydrogel exhibited osteoinductivity and immune modulation. We further implanted the SCPPBA hydrogel into a calvarial bone defect model in mice. The SCPPBA hydrogel exhibited excellent bone regeneration capacity and modulated macrophage polarization and angiogenesis in vivo. The SCPPBA hydrogel realizes the long-term controlled delivery of BMP2 and is suitable for BMP2 loaded implantation to promote bone regeneration.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic review
Systematic Review with a reported sample of 609 on Hair Loss, Immune Modulation, Autoimmune Research, published in Dermatol Reports (2026) — summary generated from the PubMed abstract.
- 2026
- n = 609
Dermatol Reports - Level ASystematic ReviewPubMed
Regeneration in Aesthetic Medicine: Mechanisms, Evidence, and Clinical Boundaries.
Systematic Review on Skin Aging, Immune Modulation, published in J Cosmet Dermatol (2026) — summary generated from the PubMed abstract.
- 2026
J Cosmet Dermatol - Level ASystematic ReviewEurope PMC
Molecular and Regenerative Effects of Platelet-Rich Plasma and Related Hemocomponents in Animal Models of Liver Injury-A Systematic Review
Systematic Review on Immune Modulation, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci - Level ASystematic ReviewPubMed
Stromal Vascular Fraction in Bone Healing: A Systematic Review of Clinical Evidence and Potential Implications in Skull Base Reconstruction and Cranioplasty.
Systematic Review with a reported sample of 214 on Chronic Wound, Immune Modulation, published in J Craniofac Surg (2026) — summary generated from the PubMed abstract.
- 2026
- n = 214
J Craniofac Surg - Level AMeta-analysisEurope PMC
The efficacy and safety of MSCs in GVHD prevention and the treatment of SR-aGVHD: a systematic review and meta-analysis of randomized controlled trials
Meta-analysis on Immune Modulation, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther - Level ASystematic ReviewEurope PMC
Harnessing exosomes in dry eye disease: a triple threat approach
Systematic Review on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in BMC Ophthalmol (2026) — summary generated from the PubMed abstract.
- 2026
BMC Ophthalmol